RecruitingNCT05438537
A Comprehensive Prospective Assessment of the Physical and Biological Effects of Upper Tract Urothelial Cancer (UTUC)
Sponsor
Chinese University of Hong Kong
Enrollment
300 participants
Start Date
Nov 1, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
There are many controversies and limitations in the management of Upper Tract Urothelial cancer. A prospective registry is set up for patients in our hospital, aim to have a comprehensive prospective assessment of the physical and biological effects of Upper Tract Urothelial cancer in our patients
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Male patients > 18 years old
- Patients who has presence of UTUC and pending for surgery
- Patients who has history of UTUC with any intervention performed
Exclusion Criteria1
- \- Patients fail to provide informed consent
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05438537
Related Trials
Urine Methylation Markers in UTUC
NCT068056301 location
SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma
NCT068220101 location
Single-Port RAS Using Da Vinci SP Surgical System for UTUC Patients
NCT069875521 location
DDR Genes Alteration and Response to Platinum-based Chemotherapy in Advanced Urothelial Cancer.
NCT068202551 location